Published in Diabetes Res Clin Pract on September 01, 1999
Foreign body-type multinucleated giant cell formation is potently induced by alpha-tocopherol and prevented by the diacylglycerol kinase inhibitor R59022. Am J Pathol (2003) 0.96
Alpha-tocopherol: looking beyond an antioxidant. Mol Vis (2009) 0.92
Breviscapine inhibits high glucose-induced proliferation and migration of cultured vascular smooth muscle cells of rats via suppressing the ERK1/2 MAPK signaling pathway. Acta Pharmacol Sin (2012) 0.84
Wogonin ameliorates lipotoxicity-induced apoptosis of cultured vascular smooth muscle cells via interfering with DAG-PKC pathway. Acta Pharmacol Sin (2011) 0.84
Hyper-reactivity of diacylglycerol kinase is involved in the dysfunction of aortic smooth muscle contractility in streptozotocin-induced diabetic rats. Br J Pharmacol (2002) 0.84
Fatty acids inhibit growth-factor-induced diacylglycerol kinase alpha activation in vascular smooth-muscle cells. Biochem J (2001) 0.82
Diabetes diminishes phosphatidic acid in the retina: a putative mediator for reduced mTOR signaling and increased neuronal cell death. Invest Ophthalmol Vis Sci (2012) 0.78
Complex modulation of the expression of PKC isoforms in the rat brain during chronic type 1 diabetes mellitus. Brain Res (2012) 0.76
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A (1995) 5.92
Diabetic retinopathy. Diabetes Care (1998) 3.39
Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart. Circulation (1999) 3.35
Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest (1999) 3.18
Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes (1997) 3.08
Protein kinase C activation and the development of diabetic complications. Diabetes (1998) 2.93
Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science (1996) 2.80
Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci U S A (1992) 2.48
Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. Proc Natl Acad Sci U S A (1989) 2.45
Receptor-mediated transport of insulin across endothelial cells. Science (1985) 2.42
Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J Clin Invest (1996) 2.36
Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes (1999) 2.21
Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo : a specific vascular action of insulin. Circulation (2000) 2.18
Direct demonstration of separate receptors for growth and metabolic activities of insulin and multiplication-stimulating activity (an insulinlike growth factor) using antibodies to the insulin receptor. J Clin Invest (1980) 2.15
Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy. Proc Natl Acad Sci U S A (1997) 2.02
Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest (1985) 2.00
Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J (2000) 1.93
Involvement of N-methyl-D-aspartate receptors in epileptiform bursting in the rat hippocampal slice. J Physiol (1986) 1.83
High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type 1 diabetes. Diabetes Care (1999) 1.78
Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes (1994) 1.75
Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest (1997) 1.75
Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J Clin Invest (1999) 1.72
Insulin receptors, receptor antibodies, and the mechanism of insulin action. Recent Prog Horm Res (1981) 1.68
Identification of PKC-isoform-specific biological actions using pharmacological approaches. Trends Pharmacol Sci (2000) 1.67
Vascular endothelial growth factor induces expression of connective tissue growth factor via KDR, Flt1, and phosphatidylinositol 3-kinase-akt-dependent pathways in retinal vascular cells. J Biol Chem (2000) 1.67
Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes (1993) 1.60
Porcine diacylglycerol kinase sequence has zinc finger and E-F hand motifs. Nature (1990) 1.57
A monoclonal antibody (3G5)-defined ganglioside antigen is expressed on the cell surface of microvascular pericytes. J Exp Med (1988) 1.55
Protein kinase C and the development of diabetic vascular complications. Diabet Med (2001) 1.42
Identification of the gene encoding the major NAD(P)H-flavin oxidoreductase of the bioluminescent bacterium Vibrio fischeri ATCC 7744. J Bacteriol (1994) 1.42
Diacylglycerol kinase from pig brain. Purification and phospholipid dependencies. J Biol Chem (1983) 1.41
Molecular cloning of a novel diacylglycerol kinase isozyme with a pleckstrin homology domain and a C-terminal tail similar to those of the EPH family of protein-tyrosine kinases. J Biol Chem (1996) 1.40
Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. Am J Physiol (1993) 1.36
Retracted Differential regulation of protein kinase C and (Na,K)-adenosine triphosphatase activities by elevated glucose levels in retinal capillary endothelial cells. J Clin Invest (1989) 1.36
Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells. Diabetes (1995) 1.35
Chaperone function of calreticulin when expressed in the endoplasmic reticulum as the membrane-anchored and soluble forms. J Biol Chem (1995) 1.35
Cloning and characterization of two human isozymes of Mg2+-independent phosphatidic acid phosphatase. J Biol Chem (1997) 1.34
Stimulation of endothelin-1 gene expression by insulin in endothelial cells. J Biol Chem (1991) 1.34
Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus. J Mol Med (Berl) (1998) 1.28
Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells. J Clin Invest (1995) 1.24
Selectivity of the diacylglycerol kinase inhibitor 3-[2-(4-[bis-(4-fluorophenyl)methylene]-1-piperidinyl)ethyl]-2, 3-dihydro-2-thioxo-4(1H)quinazolinone (R59949) among diacylglycerol kinase subtypes. Biochem Pharmacol (2000) 1.24
Identification of the mechanism for the inhibition of Na+,K(+)-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2. J Clin Invest (1995) 1.24
Vascular dysfunction in diabetes mellitus. Lancet (1997) 1.23
In vivo phosphorylation of cardiac troponin I by protein kinase Cbeta2 decreases cardiomyocyte calcium responsiveness and contractility in transgenic mouse hearts. J Clin Invest (1998) 1.22
Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1. Invest Ophthalmol Vis Sci (1996) 1.21
Receptor-mediated vectorial transcytosis of epidermal growth factor by Madin-Darby canine kidney cells. J Cell Biol (1987) 1.20
Glucose induced genes in bovine aortic smooth muscle cells identified by mRNA differential display. FASEB J (1994) 1.20
Regulation of insulin receptor internalization in vascular endothelial cells by insulin and phorbol ester. J Biol Chem (1987) 1.18
Thiazolidinedione compounds ameliorate glomerular dysfunction independent of their insulin-sensitizing action in diabetic rats. Diabetes (2000) 1.18
Phosphatidic acid generation through interleukin 2 (IL-2)-induced alpha-diacylglycerol kinase activation is an essential step in IL-2-mediated lymphocyte proliferation. J Biol Chem (1996) 1.15
Molecules in focus: diacylglycerol kinase. Int J Biochem Cell Biol (1997) 1.15
Glucocorticoid-induced diabetes mellitus: prevalence and risk factors in primary renal diseases. Nephron Clin Pract (2006) 1.15
Gene cloning, sequence, expression and in situ localization of 80 kDa diacylglycerol kinase specific to oligodendrocyte of rat brain. Brain Res Mol Brain Res (1992) 1.14
Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes (2000) 1.13
Insulin stimulates serine and tyrosine phosphorylation in the juxtamembrane region of the insulin receptor. J Biol Chem (1993) 1.12
The role of protein kinase C activation in diabetic nephropathy. Kidney Int Suppl (2007) 1.12
Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. Am J Physiol (1994) 1.11
Normalization of retinal blood flow in diabetic rats with primary intervention using insulin pumps. Invest Ophthalmol Vis Sci (1994) 1.10
Endothelin-1 modulates insulin signaling through phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. Diabetes (1999) 1.10
Promotion of transferrin folding by cyclic interactions with calnexin and calreticulin. EMBO J (1997) 1.10
Immunological characterization of sn-1,2-diacylglycerol and sn-2-monoacylglycerol kinase from pig brain. J Biol Chem (1986) 1.10
Porcine 80-kDa diacylglycerol kinase is a calcium-binding and calcium/phospholipid-dependent enzyme and undergoes calcium-dependent translocation. J Biol Chem (1991) 1.10
The C-terminal part of diacylglycerol kinase alpha lacking zinc fingers serves as a catalytic domain. Biochem J (1996) 1.09
Characterization of a common high-affinity receptor for reovirus serotypes 1 and 3 on endothelial cells. J Virol (1989) 1.08
Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway. Am J Physiol (1995) 1.06
Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells. Invest Ophthalmol Vis Sci (1996) 1.06
Insulin, insulin-like growth factor I and platelet-derived growth factor interact additively in the induction of the protooncogene c-myc and cellular proliferation in cultured bovine aortic smooth muscle cells. Mol Endocrinol (1989) 1.05
Acupuncture: is it effective for treatment of insulin resistance? Diabetes Obes Metab (2010) 1.05
Air oxidation effects on microporosity, surface property, and CH4 adsorptivity of pitch-based activated carbon fibers. J Colloid Interface Sci (2004) 1.05
Inhibitory effect of Friend leukemia virus infection on the antibody formation to sheep erythrocytes in mice. Jpn J Exp Med (1966) 1.05
Evaluating retinal circulation using video fluorescein angiography in control and diabetic rats. Curr Eye Res (1992) 1.04
Regulation of receptor-mediated endocytosis by phorbol esters. Biochem Pharmacol (1991) 1.03
Characterization of induction of protooncogene c-myc and cellular growth in human vascular smooth muscle cells by insulin and IGF-I. Diabetes (1989) 1.03
Substrate-selectivity of rat liver microsomal 1,2-diacylglycerol: CDP-choline(ethanolamine) choline(ethanolamine)phosphotransferase in utilizing endogenous substrates. Biochim Biophys Acta (1975) 1.03
Identification and characterization of vascular endothelial growth factor receptor (Flt) in bovine retinal pericytes. Diabetes (1996) 1.02
Molecular cloning of a diacylglycerol kinase isozyme predominantly expressed in human retina with a truncated and inactive enzyme expression in most other human cells. J Biol Chem (1994) 1.02
Different effects of sphingosine, R59022 and anionic amphiphiles on two diacylglycerol kinase isozymes purified from porcine thymus cytosol. FEBS Lett (1989) 1.02
Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells. Invest Ophthalmol Vis Sci (1996) 1.02
Non-parallel evolution of metabolic and growth-promoting functions of insulin. Nature (1981) 1.02
Identification of multiple genes in bovine retinal pericytes altered by exposure to elevated levels of glucose by using mRNA differential display. Proc Natl Acad Sci U S A (1994) 1.01
Retracted Endothelin stimulates a sustained 1,2-diacylglycerol increase and protein kinase C activation in bovine aortic smooth muscle cells. Biochem Biophys Res Commun (1989) 1.01
Protein kinase C activation and its pharmacological inhibition in vascular disease. Vasc Med (2000) 1.00
Normalization of diacylglycerol-protein kinase C activation by vitamin E in aorta of diabetic rats and cultured rat smooth muscle cells exposed to elevated glucose levels. Diabetes (1994) 1.00
Interactions between the receptors for insulin and the insulin-like growth factors on adipocytes. J Biol Chem (1982) 1.00
Differential responsiveness to insulin of endothelial and support cells from micro- and macrovessels. J Clin Invest (1983) 1.00
Endothelin-1 induces cyclooxygenase-2 expression via nuclear factor of activated T-cell transcription factor in glomerular mesangial cells. J Am Soc Nephrol (2001) 1.00
Processing of insulin by bovine endothelial cells in culture. Internalization without degradation. Diabetes (1984) 0.98
Endothelin-1 action via endothelin receptors is a primary mechanism modulating retinal circulatory response to hyperoxia. Invest Ophthalmol Vis Sci (1996) 0.98
Multiplication stimulating activity (MSA) from the BRL 3A rat liver cell line: relation to human somatomedins and insulin. J Supramol Struct Cell Biochem (1981) 0.98
Human vascular smooth muscle cells of diabetic origin exhibit increased proliferation, adhesion, and migration. J Vasc Surg (2001) 0.97
Cell surface activities of the human type 2b phosphatidic acid phosphatase. J Biochem (2000) 0.97
The regulatory role of EF-hand motifs of pig 80K diacylglycerol kinase as assessed using truncation and deletion mutants. Biochem Biophys Res Commun (1991) 0.97
Endothelial dysfunction in diabetes mellitus: role in cardiovascular disease. Heart Fail Monit (2001) 0.97
Biosynthesis of molecular species of phosphatidyl choline and phosphatidyl ethanolamine from radioactive precursors in rat liver slices. Biochim Biophys Acta (1969) 0.97
Cellular mechanisms in the development and progression of diabetic nephropathy: activation of the DAG-PKC-ERK pathway. Am J Kidney Dis (2001) 0.97
Phospholipase D activation by platelet-activating factor, leukotriene B4, and formyl-methionyl-leucyl-phenylalanine in rabbit neutrophils. Phospholipase D activation is involved in enzyme release. J Immunol (1991) 0.96